对于以前没有服用过生物药的患有牛皮关节炎的患者来说,不同的生物药物:系统性审查和网络元分析
1Department of Rheumatism and Immunology, Ningbo No.6 Hospital, Ningbo, Zhejiang, China.
Frontiers in pharmacology
|March 28, 2024
概括
干白素-17A抑制剂 (IL-17Ai) 显示出作为生物先验牛皮关节炎 (PsA) 患者的首选治疗方法的希望. 这项系统性审查比较了各种生物药物,发现IL-17Ai对肠炎和牙炎的解决有效.
科学领域:
- 类风湿病学 类风湿病学
- 免疫学 免疫学 免疫学
- 药理学 药理学是指药理学的学科.
背景情况:
- 牛皮关节炎 (PsA) 是一种慢性炎症疾病,需要有效的生物疗法.
- 生物学上天真的患者是启动先进治疗策略的关键人群.
- 对比不同生物类的疗效和安全性对于优化PsA管理至关重要.
研究的目的:
- 系统地比较各种生物药物的有效性和安全性,对生物素先验的PsA患者进行比较.
- 为了评估瘤缩因子抑制剂 (TNFi),介素 (IL) 抑制剂,固酶-4抑制剂 (PDE4i) 和简氏激酶抑制剂 (JAKi).
- 以头对头比较来确定最佳的生物治疗选择.
主要方法:
- 对头对头主动比较研究的系统审查和网络元分析.
- 在PubMed,科学网,Embase和Cochrane图书馆搜索到2023年3月.
- 使用Jadad和NOS尺度评估肌肉骨,功能,复合终点和不良事件.
主要成果:
- 干白素-17A抑制剂 (IL-17Ai) 显示出更高的肠炎解消率,甲状腺炎解消率和功能改善率 (HAQ-DI).
- 雅努斯激酶抑制剂 (JAKi) 显示出实现ACR 70反应的最大潜力.
- 固酶-4抑制剂 (PDE4i) 与最少的不良事件发生率有关.
结论:
- IL-17Ai可能是生物先验PsA患者的最佳选择,平衡有效性和安全性.
- 选择生物应考虑患者的具体需求,包括解决关键的PsA症状.
- 进一步的研究可能会探索所有生物类的长期结果和比较有效性.
相关概念视频
Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF
137
Tumor Necrosis Factor (TNF), a proinflammatory cytokine, contributes significantly to the inflammation seen in Crohn's disease. It exists as soluble TNF and membrane-bound TNF, with actions mediated through TNF receptors (TNFR). TNFR activation leads to the release of proinflammatory cytokines, T-cell activation, collagen production, and leukocyte migration, all contributing to inflammation in Crohn's disease. Anti-TNF monoclonal antibodies, namely infliximab (Remicade), adalimumab...
137
T Cell Types and Functions
1.0K
When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
1.0K
The JAK-STAT Signaling Pathway
8.9K
Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as SH2...
8.9K


